Analysis of disease burden of testicular cancer in China from 1990 to 2019
10.11855/j.issn.0577-7402.2345.2023.0328
- VernacularTitle:1990-2019年中国睾丸癌疾病负担分析
- Author:
Shi-Di TANG
1
,
2
;
Hao ZI
;
Cong ZHU
;
Yong-Bo WANG
;
Xian-Tao ZENG
Author Information
1. 武汉大学中南医院泌尿外科,湖北武汉 430071
2. 武汉大学中南医院循证与转化医学中心,湖北武汉 430071
- Keywords:
testicular cancer;
disease burden;
incidence;
mortality;
disability-adjusted life years
- From:
Medical Journal of Chinese People's Liberation Army
2024;49(3):272-279
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the burden and changing trend of testicular cancer in China from 1990 to 2019.Methods Based on the 2019 Global Burden of Disease Database(GBD 2019),analyze the incidence,mortality,disability-adjusted life years(DALYs),years of life lost(YLLs),years lived with disability(YLDs)and their variation trend of testicular cancer in Chinese population from 1990 to 2019.Evaluating changes in age standardized rate(ASR)by calculating annual estimated percentage change(EAPC).According to the age grouping,analyze the age distribution characteristics of testicular cancer disease burden by age group.Results In 2019,the incident cases,deaths,age-standardized incidence rate,and age-standardized mortality rate of testicular cancer in China were 17.17×103,1.21×103,2.39/105,and 0.16/105,respectively.Compared to 1990,incident cases,deaths,and age-standardized incidence rate increased obviously in China,which was consistent with the global change trend,while the increase was higher than the global level.However,both Chinese and global age-standardized mortality rate showed a downward trend.From 1990 to 2019,DALYs,YLLs and YLDs of testicular cancer increased by 29.66%,9.83%and 720.91%respectively in China.The two age groups,0-15 years group and 30-35 years group,were with highest incidence of testicular cancer,while the highest disease burden of testicular cancer was 30-35 years.Conclusion From 1990 to 2019,the disease burden of testicular cancer in China showed an upward trend.Adolescents and young adults should be the priority population for screening and prevention due to their higher incidence and disease burden.
